Anti-PIGG monoclonal antibody

Pre-made anti-PIGG monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PIGG/PIGG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1390-Ab-1/ GM-Tg-hg-IP1390-Ab-2Anti-Human PIGG monoclonal antibodyHuman
GM-Tg-rg-IP1390-Ab-1/ GM-Tg-rg-IP1390-Ab-2Anti-Rat PIGG monoclonal antibodyRat
GM-Tg-mg-IP1390-Ab-1/ GM-Tg-mg-IP1390-Ab-2Anti-Mouse PIGG monoclonal antibodyMouse
GM-Tg-cynog-IP1390-Ab-1/ GM-Tg-cynog-IP1390-Ab-2Anti-Cynomolgus/ Rhesus macaque PIGG monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1390-Ab-1/ GM-Tg-felg-IP1390-Ab-2Anti-Feline PIGG monoclonal antibodyFeline
GM-Tg-cang-IP1390-Ab-1/ GM-Tg-cang-IP1390-Ab-2Anti-Canine PIGG monoclonal antibodyCanine
GM-Tg-bovg-IP1390-Ab-1/ GM-Tg-bovg-IP1390-Ab-2Anti-Bovine PIGG monoclonal antibodyBovine
GM-Tg-equg-IP1390-Ab-1/ GM-Tg-equg-IP1390-Ab-2Anti-Equine PIGG monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1390-Ab-1/ GM-Tg-hg-IP1390-Ab-2; GM-Tg-rg-IP1390-Ab-1/ GM-Tg-rg-IP1390-Ab-2;
GM-Tg-mg-IP1390-Ab-1/ GM-Tg-mg-IP1390-Ab-2; GM-Tg-cynog-IP1390-Ab-1/ GM-Tg-cynog-IP1390-Ab-2;
GM-Tg-felg-IP1390-Ab-1/ GM-Tg-felg-IP1390-Ab-2; GM-Tg-cang-IP1390-Ab-1/ GM-Tg-cang-IP1390-Ab-2;
GM-Tg-bovg-IP1390-Ab-1/ GM-Tg-bovg-IP1390-Ab-2; GM-Tg-equg-IP1390-Ab-1/ GM-Tg-equg-IP1390-Ab-2
Products NameAnti-PIGG monoclonal antibody
Formatmab
Target NamePIGG
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PIGG monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1390-Ag-1Recombinant multi-species PIGG/ GPI7/ LAS21 protein


    Target information

    Target IDGM-IP1390
    Target NamePIGG
    Gene ID54872,433931,100910143,714088,479136,101095255,511496,100050713
    Gene Symbol and SynonymsEMM,GPI7,LAS21,MRT53,NEDHSCA,PIGG,PRO4405,RGD1560335,RLGS1930
    Uniprot AccessionQ5H8A4
    Uniprot Entry NamePIGG_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000174227
    Target ClassificationN/A

    The target: PIGG, gene name: PIGG, also named as GPI7, LAS21, MRT53, PRO4405, RLGS1930. This gene encodes an enzyme involved in glycosylphosphatidylinositol-anchor biosynthesis. The encoded protein, which is localized to the endoplasmic reticulum, is involved in transferring ethanoloamine phosphate to mannose 2 of glycosylphosphatidylinositol species H7 to form species H8. Allelic variants of this gene have been associated with intellectual disability, hypotonia, and early-onset seizures. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.